34943114|t|Umuhengerin Neuroprotective Effects in Streptozotocin-Induced Alzheimer's Disease Mouse Model via Targeting Nrf2 and NF-Kbeta Signaling Cascades.
34943114|a|Alzheimer's disease (AD) is the most common type of dementia and is characterized by advanced cognitive deterioration, deposition of Abeta (amyloid-beta), and the formation of neurofibrillary tangles. Administration of streptozotocin (STZ) via the intracerebroventricular (ICV) route is a reliable model resembling sporadic AD (SAD) associated neuropathological changes. The present study was undertaken to explore the neuroprotective effects of the methoxy flavonoid, umuhengerin, in an STZ-induced SAD mouse model as a potential therapy for AD. Mice were injected once with STZ (3 mg/kg, ICV), followed by daily administration of umuhengerin (orally, 30 mg/kg) or the positive control donepezil (orally, 2.5 mg/kg) for 21 days. The pharmacological activity of umuhengerin was assessed through estimation of oxidative stress and inflammatory markers via mouse ELISA kits, Western blot analysis, and brain histopathological examination. Morris water maze test was also conducted to investigate umuhengerin-induced cognitive enhancement. The results showed that umuhengerin attenuated STZ-produced neuroinflammation and oxidative stress with a notable rise in the expression of Nrf2 (nuclear factor erythroid 2-related factor 2). In contrast, it downregulated Keap-1 (Kelch-like ECH associated protein 1), as well as elevated brain contents of GSH (reduced glutathione) and HO-1 (heme oxygenase-1). STZ-injected animals receiving umuhengerin showed marked downregulation of the nuclear factor kappa beta (NF-Kbetap65) and noticeable increment in the expression of its inhibitor kappa beta alpha protein (IKbetaalpha), as well as prominent reduction in malondialdehyde (MDA), H2O2 (hydrogen peroxide), and TNF-alpha (tumor-necrosis factor-alpha) contents. Beta-secretase protein expression and acetylcholinesterase (AchE) activity were also diminished upon umuhengerin injection in the STZ group, leading to decreased Abeta formation and cognitive improvement, respectively. In conclusion, umuhengerin neuroprotective effects were comparable to the standard drug donepezil; thus, it could be an alternative approach for AD management.
34943114	0	11	Umuhengerin	Chemical	MESH:C057913
34943114	39	53	Streptozotocin	Chemical	MESH:D013311
34943114	62	81	Alzheimer's Disease	Disease	MESH:D000544
34943114	82	87	Mouse	Species	10090
34943114	108	112	Nrf2	Gene	18024
34943114	146	165	Alzheimer's disease	Disease	MESH:D000544
34943114	167	169	AD	Disease	MESH:D000544
34943114	198	206	dementia	Disease	MESH:D003704
34943114	240	263	cognitive deterioration	Disease	MESH:D003072
34943114	279	284	Abeta	Gene	11820
34943114	322	345	neurofibrillary tangles	Disease	MESH:D055956
34943114	365	379	streptozotocin	Chemical	MESH:D013311
34943114	381	384	STZ	Chemical	MESH:D013311
34943114	461	472	sporadic AD	Disease	MESH:D000544
34943114	474	477	SAD	Disease	MESH:D000544
34943114	490	507	neuropathological	Disease	MESH:D009422
34943114	596	613	methoxy flavonoid	Chemical	-
34943114	615	626	umuhengerin	Chemical	MESH:C057913
34943114	634	637	STZ	Chemical	MESH:D013311
34943114	646	649	SAD	Disease	MESH:D000544
34943114	650	655	mouse	Species	10090
34943114	689	691	AD	Disease	MESH:D000544
34943114	693	697	Mice	Species	10090
34943114	722	725	STZ	Chemical	MESH:D013311
34943114	778	789	umuhengerin	Chemical	MESH:C057913
34943114	833	842	donepezil	Chemical	MESH:D000077265
34943114	908	919	umuhengerin	Chemical	MESH:C057913
34943114	976	988	inflammatory	Disease	MESH:D007249
34943114	1001	1006	mouse	Species	10090
34943114	1140	1151	umuhengerin	Chemical	MESH:C057913
34943114	1160	1181	cognitive enhancement	Disease	MESH:D003072
34943114	1207	1218	umuhengerin	Chemical	MESH:C057913
34943114	1230	1233	STZ	Chemical	MESH:D013311
34943114	1243	1260	neuroinflammation	Disease	MESH:D000090862
34943114	1323	1327	Nrf2	Gene	18024
34943114	1329	1372	nuclear factor erythroid 2-related factor 2	Gene	18024
34943114	1405	1411	Keap-1	Gene	50868
34943114	1413	1448	Kelch-like ECH associated protein 1	Gene	50868
34943114	1489	1492	GSH	Chemical	MESH:D005978
34943114	1494	1513	reduced glutathione	Chemical	MESH:D005978
34943114	1519	1523	HO-1	Gene	15368
34943114	1525	1541	heme oxygenase-1	Gene	15368
34943114	1544	1547	STZ	Chemical	MESH:D013311
34943114	1575	1586	umuhengerin	Chemical	MESH:C057913
34943114	1749	1760	IKbetaalpha	Gene	18035
34943114	1797	1812	malondialdehyde	Chemical	MESH:D008315
34943114	1814	1817	MDA	Chemical	MESH:D008315
34943114	1820	1824	H2O2	Chemical	MESH:D006861
34943114	1826	1843	hydrogen peroxide	Chemical	MESH:D006861
34943114	1850	1859	TNF-alpha	Gene	21926
34943114	1861	1888	tumor-necrosis factor-alpha	Gene	21926
34943114	1938	1958	acetylcholinesterase	Gene	11423
34943114	1960	1964	AchE	Gene	11423
34943114	2001	2012	umuhengerin	Chemical	MESH:C057913
34943114	2030	2033	STZ	Chemical	MESH:D013311
34943114	2062	2067	Abeta	Gene	11820
34943114	2134	2145	umuhengerin	Chemical	MESH:C057913
34943114	2207	2216	donepezil	Chemical	MESH:D000077265
34943114	2264	2266	AD	Disease	MESH:D000544
34943114	Negative_Correlation	MESH:C057913	MESH:D006861
34943114	Negative_Correlation	MESH:C057913	MESH:D000090862
34943114	Negative_Correlation	MESH:D000077265	MESH:D000544
34943114	Positive_Correlation	MESH:C057913	18024
34943114	Positive_Correlation	MESH:D013311	MESH:D000090862
34943114	Positive_Correlation	MESH:C057913	MESH:D003072
34943114	Positive_Correlation	MESH:C057913	50868
34943114	Association	MESH:D006861	MESH:D013311
34943114	Negative_Correlation	MESH:C057913	MESH:D013311
34943114	Negative_Correlation	MESH:C057913	11423
34943114	Negative_Correlation	MESH:C057913	MESH:D000544
34943114	Positive_Correlation	MESH:C057913	18035
34943114	Positive_Correlation	MESH:C057913	15368
34943114	Association	MESH:D000544	11820
34943114	Negative_Correlation	MESH:C057913	MESH:D008315
34943114	Negative_Correlation	MESH:C057913	21926
34943114	Positive_Correlation	MESH:C057913	MESH:D005978
34943114	Association	MESH:D013311	18024
34943114	Positive_Correlation	MESH:D013311	MESH:D000544

